JLE

Epileptic Disorders

MENU

Real-world evaluation of perampanel effectiveness in Japanese adolescents with epilepsy Volume 24, numéro 5, October 2022

Figure 1.

Perampanel retention rates (safety analysis set) calculated using the Kaplan–Meier method.

Figure 2.

Occurrence of adverse effects by initial dose and titration interval (safety analysis set).aTwo patients who took an initial perampanel dose of 4 mg were excluded from the analysis.bPatients who had a titration interval ≥eight weeks were excluded from the analysis as the distribution of the titration interval was wide (8-102 weeks). CI: confidence interval; OR: odds ratio.

Figure 3.

Responder rates (efficacy analysis set). FAS: focal aware seizures; FBTCS: focal to bilateral tonic-clonic seizures; FIAS: focal impaired awareness seizures; GTCS: generalized tonic-clonic seizures.